Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Hunt For Blood Test To Determine Melanoma Survival Rates
Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. Melanoma is the most aggressive form of skin cancer. Staging, which involves determining the size of the tumour and its extent of spread, is the best predictor of whether a patient will succumb to disease or survive.

HeartWorks Simulation - A Breakthrough In Education For Cardiothoracic Anesthesiologists
The world"s first virtual heart has been developed to improve teaching of peri-operative transesophageal echocardiography (TEE) skills in the care of patients with heart disease. HeartWorks, a uniquely realistic computer-generated model of the heart and echocardiography simulator, is the result of a 4 year project driven by a team of three London-based cardiac anaesthesiologists. Recognising the power of education through simulation and its increasingly widespread adoption throughout clinical practice, the team is spearheading a pathway change in education in one of the most interesting and challenging areas of cardiac care. Now in production by Inventive Medical, a subsidiary of UCLH Charity London, HeartWorks is set to dramatically transform TEE training by university teaching hospitals worldwide.
News of the day
Global Public Health Threat Continues From Lead-Based Consumer Paint
Although lead content in paint has been restricted in the United States since 1978, University of Cincinnati (UC) environmental health researchers say in major countries from three continents there is still widespread failure to acknowledge its danger and companies continue to sell consumer paints that contain dangerous levels of lead.
Health Insurance

Grants To Fund Research Critical To US And Honors From White House

Benjamin tenOever, Ph.D., Assistant Professor in the Department of Microbiology at Mount Sinai School of Medicine, has been selected by the United States government for a Presidential Early Career Award for Scientists and Engineers (PECASE). The White House announced the 100 honorees on July 9 and will host them at a reception with President Barack Obama. The highest honor bestowed by the country on young professionals in the early stages of their research careers, the award comes with $500,000 in research funding over a five year span. The Department of Defense, which nominated Dr. tenOever, will match this amount, giving him $1 million for research over five years. Dr. tenOever"s lab focuses on developing novel vaccine strategies to combat influenza virus and other emerging pathogens. "My receipt of this Presidential Award reflects the priority Mount Sinai School of Medicine places on discoveries that have immediate impact on human health," said Dr. tenOever. "This is truly one of the greatest honors bestowed upon me thus far in my career, and my work is just one of scores of translational research projects the Medical School has made possible through its commitment to breakthrough science." In a White House press release, President Obama called the honorees "the best in our country" and said he is confident they will "help us use science and technology to lift up our nation and our world." Nominees are chosen annually by nine Federal departments and agencies. Award selections are based on two criteria: pursuit of innovative research at the frontiers of science, and technology and a commitment to community service. Dr. tenOever and his team study cellular response to RNA virus infections - the genetic interactions that occur within cells attacked by virus - as well as processes that render cells resistant to infection, in the hope of reducing the global burden from such pathogens. "The National Science and Technology Council"s recognition of Dr. tenOever"s work and contributions will help us further the study of viral infection," said Dennis S. Charney, M.D., the Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "Mount Sinai"s ability to secure research funding, such as the Presidential Award, is critical to our mission of discovering tomorrow"s cures today." This is not the first time Dr. tenOever"s research has earned accolades. A year ago, he was selected as a Pew Scholar in the Biomedical Sciences, an honor that acknowledges and supports promising young investigators in advancing human health. Dr. tenOever was one of 20 scientists chosen by The Pew Charitable Trusts and the University of California at San Francisco, which provide this distinction. Dr. tenOever received a doctorate in virology from McGill University in 2004. He engaged in postdoctoral research at Harvard University from 2004 to 2007. He then joined the staff at Mount Sinai School of Medicine in the Department of Microbiology. Kevin Orozovich The Mount Sinai Hospital / Mount Sinai School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009